In Brief: Candela's GentleLASE
This article was originally published in The Gray Sheet
Executive Summary
Candela's GentleLASE: FDA clears the long-pulse alexandrite laser product for treatment of vascular lesions. Wayland, Massachusetts-based Candela says it will launch GentleLASE at a price of $59,500, "which is 50-60% lower than that of any competitive systems," with the price remaining in effect through the March 4 end of the American Academy of Dermatology meeting. Shipments are expected to begin during the first quarter of 1998...